Profil
Palle Christophersen is the founder of Cephagenix ApS, founded in 2020, and Saniona AB, founded in 2011, where the title held is Executive Vice President-Research.
The current job is Chief Scientific Officer at Saniona A. Former job includes Vice President & Director-Vitro Pharmacology at NTG Nordic Transport Group A from 1991 to 2012.
Education includes a doctorate from the University of Copenhagen.
Postes actifs de Palle Christophersen
| Sociétés | Poste | Début |
|---|---|---|
| SANA AB | Fondateur | 01/01/2011 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Palle Christophersen
| Sociétés | Poste | Fin |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01/01/2012 |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Fondateur | - |
Formation de Palle Christophersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Health Technology |
















